| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.39B | 61.77B | 61.41B | 69.63B | 52.36B | 48.33B |
| Gross Profit | 23.20B | 16.41B | 13.62B | 14.81B | 15.94B | 16.13B |
| EBITDA | 8.59B | 7.34B | 5.13B | 6.46B | 7.34B | 8.59B |
| Net Income | 2.40B | 1.95B | -1.76B | 420.15M | 953.81M | 1.61B |
Balance Sheet | ||||||
| Total Assets | 64.56B | 65.19B | 63.03B | 64.22B | 64.08B | 62.41B |
| Cash, Cash Equivalents and Short-Term Investments | 6.78B | 8.75B | 7.19B | 6.97B | 6.75B | 6.33B |
| Total Debt | 103.92M | 109.67M | 1.15B | 188.74M | 661.77M | 1.35B |
| Total Liabilities | 11.48B | 13.04B | 13.32B | 13.08B | 13.36B | 12.14B |
| Stockholders Equity | 49.75B | 48.83B | 46.44B | 47.90B | 47.51B | 47.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.64B | 35.39M | 694.82M | 3.25B | 3.37B |
| Operating Cash Flow | 0.00 | 7.76B | 4.75B | 5.54B | 7.96B | 7.83B |
| Investing Cash Flow | 0.00 | -4.94B | -5.06B | -4.09B | -4.97B | -8.67B |
| Financing Cash Flow | 0.00 | -1.40B | 299.84M | -1.05B | -1.09B | -127.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥92.42B | 8.94 | 9.07% | 3.61% | 9.39% | 77.24% | |
75 Outperform | ¥110.71B | 8.99 | 7.99% | 3.89% | 1.08% | 37.11% | |
74 Outperform | ¥79.62B | 19.04 | ― | 2.88% | 2.77% | 10.64% | |
73 Outperform | ¥488.92B | 28.19 | 6.03% | 1.81% | 7.08% | 43.50% | |
69 Neutral | ¥24.26B | -17.01 | ― | 2.18% | 6.66% | ― | |
66 Neutral | $17.65B | 18.10 | 5.60% | 3.62% | 6.62% | 11.55% | |
62 Neutral | ¥45.44B | 11.82 | ― | 1.81% | 0.93% | 1212.45% |